ACTB and neoplasm: When combined with conditional LSL SBase and Actb-Cre alleles, T2/Onc2.3 transgenic carrier mice (hereafter, SB-Onc2.3) exhibited high rates of whole-body transposition that resulted in tumor formation (Figure 1b and Figure S5a–c).